LAMC3
protein-codinglaminin subunit gamma 3, the group of Laminin subunits
Gene summary
Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 3. The gamma 3 chain is most similar to the gamma 1 chain, and contains all the 6 domains expected of the gamma chain. It is a component of laminin 12. The gamma 3 chain is broadly expressed in skin, heart, lung, and the reproductive tracts. In skin, it is seen within the basement membrane of the dermal-epidermal junction at points of nerve penetration. Gamma 3 is also a prominent element of the apical surface of ciliated epithelial cells of lung, oviduct, epididymis, ductus deferens, and seminiferous tubules. The distribution of gamma 3-containing laminins along ciliated epithelial surfaces suggests that the apical laminins are important in the morphogenesis and structural stability of the ciliated processes of these cells. [provided by RefSeq, Aug 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~85.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*LAMC3* encodes the laminin subunit gamma 3. Laminins are extracellular matrix glycoproteins required for cell adhesion, differentiation and migration. *LAMC3* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2011 (O'Roak et al., PMID: 21572417). Over 25 unique heterozygous truncating and missense variants have been reported in sequencing studies in neurodevelopmental disorders. Autism spectrum disorder was the primary ascertainment for the largest number of individuals, but variants have also been reported in probands with intellectual disability and/or developmental delay. The variants were primarily identified in individuals with limited phenotype data from large cohort studies, and none had experimental evidence of gene impact (PMIDs: 21572417, 23160955, 27525107, 28191889, 28965761, 30564305, 31398340). These heterozygous variants are unlikely to be deleterious because they also occur in healthy individuals (PMIDs: 23160955, 31981491) and are often inherited from unaffected parents (PMIDs: 23160955, 28191889, 30564305, 31398340). Additionally, many of these variants are present at high frequency in gnomAD (v2.1.1). In agreement with these findings, *LAMC3* is not constrained for either protein truncating variants (pLI = 0, LOEUF = 0.84, gnomAD v2.1.1) or missense variation (Z score = –0.43). Thus, all the reported variants were scored 0 points. A potential mechanism of disease has not been delineated for *LAMC3* heterozygous variants, and no experimental data were identified that provided specific support for this gene-disease relationship. Of note, biallelic variants in *LAMC3* have been implicated in cortical malformations. The relationship between *LAMC3* and autosomal recessive cortical malformations will be curated separately. In summary, the evidence supporting the relationship between *LAMC3* and autosomal dominant complex neurodevelopmental disorder has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *LAMC3* plays in this disease. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on September 1, 2020 (SOP Version 7). As of July 2026, this record underwent administrative updates to update scoring to be consistent with SOP Version 12. No new evidence has been reviewed or added.
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013583
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LAMC3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006059.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 427 | 3 | 441 | ||
| missense | 725 | 76 | 7 | 808 | ||
| nonsense | 29 | 6 | 1 | 36 | ||
| start loss | 0 | |||||
| frameshift | 31 | 15 | 3 | 49 | ||
| splice donor/acceptor (+/-2bp) | 5 | 26 | 2 | 33 | ||
| Total | 65 | 47 | 742 | 503 | 10 | 1367 |
Highest pathogenic variant AF is 0.00025600623
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006050.3 | 28 | MANE Select | |
| Ensembl | ENSP00000354360.4 | 28 | MANE Select | |
| Ensembl | ENSP00000347627.5 | 6 | Standard | |
| Ensembl | ENSP00000503612.1 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| lamc3 | Danio rerio | Structure: primary motor neuron Quality: shape abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- ECM-receptor interaction - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- Small cell lung cancer - Homo sapiens (human)
- Amoebiasis - Homo sapiens (human)
Biological Process
- cell morphogenesis involved in differentiation
- cell adhesion
- visual perception
- astrocyte development
- extracellular matrix organization
Molecular Function
- structural molecule activity
Cellular Component
- extracellular region
- basement membrane
- membrane
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000361069
- Coding exons
- 28
- Length
- 85392
- Individuals with no LoFs
- 125446
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 302
- Defined
- 125748
- p
- 0.00120
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.430 | 965 | 928 | 1.04 | 0.0000639 | 10124 |
| Missense (PolyPhen) | 307 | 324.64 | 0.94567 | 3694 | ||
| Synonymous | -0.126 | 414 | 411 | 1.01 | 0.0000312 | 3163 |
| Loss of Function | 2.67 | 48 | 72.6 | 0.661 | 0.00000357 | 814 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00040 | 0.00040 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.0065 | 0.0065 | notable |
| European (Non-Finnish) | 0.00083 | 0.00082 | rare |
| South Asian | 0.00089 | 0.00088 | rare |
| Other | 0.00099 | 0.00098 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components.;
- Disease
- DISEASE: Cortical malformations occipital (OCCM) [MIM:614115]: A disease in which affected individuals develop seizures, sometimes associated with transient visual changes. Brain MRI shows both pachygyria and polymicrogyria restricted to the lateral occipital lobes. {ECO:0000269|PubMed:21572413}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.837
- RVIS EVS
- 0.64
- RVIS percentile EVS
- 83.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.987
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |